MENU
+Compare
TRML
Stock ticker: NASDAQ
AS OF
Apr 23 closing price
Price
$17.82
Change
+$0.50 (+2.89%)
Capitalization
444.86M

TRML Tourmaline Bio Forecast, Technical & Fundamental Analysis

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases... Show more

TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for TRML with price predictions
Apr 22, 2025

TRML in +8.18% Uptrend, rising for three consecutive days on April 22, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TRML advanced for three days, in of 237 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 15, 2025. You may want to consider a long position or call options on TRML as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TRML just turned positive on April 16, 2025. Looking at past instances where TRML's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

TRML moved above its 50-day moving average on April 15, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for TRML crossed bearishly below the 50-day moving average on April 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRML declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TRML broke above its upper Bollinger Band on April 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TRML entered a downward trend on April 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.529) is normal, around the industry mean (13.887). P/E Ratio (0.000) is within average values for comparable stocks, (63.180). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.782). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (251.479).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TRML’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRML’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TRML is expected to report earnings to fall 45.95% to -20 cents per share on August 10

Tourmaline Bio TRML Stock Earnings Reports
Q2'23
Est.
$-0.20
Q1'23
Beat
by $0.09
Q4'22
Missed
by $4.71
Q3'22
Missed
by $4.15
Q2'22
Missed
by $3.95
The last earnings report on May 11 showed earnings per share of -37 cents, beating the estimate of -45 cents. With 595.51K shares outstanding, the current market capitalization sits at 444.86M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
27 West 24th Street
Phone
+1 646 481-9832
Employees
44
Web
https://www.tourmalinebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYKIX92.46N/A
N/A
Rydex Banking Inv
MSRRX49.01N/A
N/A
MFS Research R2
CFAGX39.98N/A
N/A
Commerce MidCap Growth
NMANX15.10N/A
N/A
Neuberger Berman Mid Cap Growth Inv
KGIIX14.87N/A
N/A
Kopernik International I

TRML and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+3.34%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
50%
Loosely correlated
+2.37%
STOK - TRML
43%
Loosely correlated
+7.08%
IPSC - TRML
42%
Loosely correlated
N/A
SYRE - TRML
42%
Loosely correlated
+2.87%
More